"The competitive cancer-screening devices being tested right now will cost approximately $500,000, so they're limited to tertiary care centers like Mount Sinai and M.D. Anderson," said Richards-Kortum, Rice's Stanley C. Moore Professor of Bioengineering and director of Rice 360˚: Institute for Global Health Technologies. "On the other hand, we can make our device for about $2,500, and it's much less complicated. Making it work in a robust way is much, much easier," she said. Working from her new office in Rice's BioScience Research Collaborative, Richards-Kortum is following a number of paths to bring Rice innovation to public health, both in the United States and the world through Rice 360˚. She said estimates show that by 2020, at least 70 percent of cancer deaths will occur in developing countries. A low-cost, portable screening device could have great impact there. She and Tkaczyk, an assistant professor in bioengineering, are delighted at the early results from the prototype cameras, which fit in a briefcase and are powered by a laptop computer battery.
She said current needlecams are a little less than a millimeter in diameter -- not small by needle standards, but usable. She said her lab is working to reduce the size by four-fifths to 200 microns, about twice the width of a human hair. The camera itself isn't inside the needle. The optic fiber acts as a lens that transfers images to the digital camera -- in one case, a $200 camera bought at Target. "Certainly the advances in consumer electronics have contributed to our ability to do this cheaply, with off- the-shelf cameras," said Richards-Kortum. "We're really excited about the potential to use all of the advances in the consumer electronics arena to do health care with less-expensive technology." The National Institute of Biomedical Imaging and Bioengineering funded the project, which also received support from the M.D. Anderson Cancer Center. |
||||||||||||||||||||